Archivos Españoles de Urología (Ed. impresa)
versión impresa ISSN 0004-0614
TORRE ABRIL, Luis de la et al. Management of male sterility in patients taking anabolic steroids. Arch. Esp. Urol. [online]. 2005, vol.58, n.3, pp.241-244. ISSN 0004-0614.
OBJECTIVES/METHODS: To review the incidence of male infertility secondary to intake of anabolic products and our experience and outcomes with treatment. There is a variety of such substances (testosterone, nandrolone, stanozolol, etc.) in their intake may be unique or combinations, both orally or parenterally. Comparisons between patients and case series are difficult because of the hiding of this practice and various consumption practices and doses employed. RESULTS/CONCLUSIONS: Most of the patients recover normal spermatogenesis does by stopping intake of anabolic substances. The period of time until recovery is 6.35 months. Patients not recovering after six months were given tamoxifen 20 mg/24-hour, if having a normal or inhibited hypothalamus-hypophysis axis. Duration of abuse, doses, and anarchical consumption maderesponse to treatment with antiestrogen drugs or gonadotropins unpredictable in patients not responding to conservative treatment .
Palabras clave : Sterility; Anabolic steroids; Treatment.